Dr. Devarakonda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Madison St FL 2
Seattle, WA 98104Phone+1 206-386-2323Fax+1 206-215-6165
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017
St Luke's HospitalResidency, Internal Medicine, 2011 - 2014
Gandhi Medical CollegeClass of 2009
Certifications & Licensure
IL State Medical License 2020 - 2026
WA State Medical License 2022 - 2025
MO State Medical License 2014 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsPhase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer.Arun Rajan, Jhanelle E Gray, Siddhartha Devarakonda, Ruemu Birhiray, Borys Korchin
International Journal of Cancer. 2023-02-01 - 47 citationsOvercoming Chemotherapy Resistance in SCLCBrett H. Herzog, Siddhartha Devarakonda, Ramaswamy Govindan
Journal of Thoracic Oncology. 2021-08-03 - 239 citationsMYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine FateAbbie S. Ireland, Alexi M. Micinski, David W. Kastner, Bingqian Guo, Sarah J. Wait
Cancer Cell. 2020-07-13
Journal Articles
- Targeting Resistance to Targeted Therapies: Combating a Resilient FoeSiddhartha Devarakonda, Ramaswamy Govindan, Clinical Cancer Research
Authored Content
- Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small-Cell Lung CancerFebruary 2018
Press Mentions
Some Lung Cancer Patients See Big Breakthrough with New DrugJune 11th, 2021- Friday: New Drug Provides Breakthrough for Some Lung Cancer PatientsJune 10th, 2021
Biomarkers Advances Continue to Drive Progress in NSCLCMay 3rd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
